-
Mashup Score: 1FDA Approves Cologuard Plus for Adults at Average Risk for CRC - 3 month(s) ago
The FDA has approved Cologuard Plus, a next-generation multitarget stool DNA test, for adults at least 45 years of age who are at average risk for CRC.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1FDA Approves Cologuard Plus for Adults at Average Risk for CRC - 3 month(s) ago
The FDA has approved Cologuard Plus, a next-generation multitarget stool DNA test, for adults at least 45 years of age who are at average risk for CRC.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
FDA Approves Cologuard Plus for Adults at Average Risk for CRC. #oncology #CRC https://t.co/qwbnaCBn4D
-
-
Mashup Score: 1FDA Approves Cologuard Plus for Adults at Average Risk for CRC - 3 month(s) ago
The FDA has approved Cologuard Plus, a next-generation multitarget stool DNA test, for adults at least 45 years of age who are at average risk for CRC.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
FDA Approves Cologuard Plus for Adults at Average Risk for CRC. #oncology #CRC https://t.co/qwbnaCBn4D
-
-
Mashup Score: 0
CHMP has voiced its support for the approval of fruquintinib in previously treated metastatic colorectal cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Fruquintinib Receives Positive EU CHMP Opinion for Previously Treated mCRC. #oncology #CRC https://t.co/eYUPBvHqU7
-
-
Mashup Score: 0
CHMP has voiced its support for the approval of fruquintinib in previously treated metastatic colorectal cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Fruquintinib Receives Positive EU CHMP Opinion for Previously Treated mCRC. #oncology #CRC https://t.co/eYUPBvHqU7
-
-
Mashup Score: 1Multitargeted DNA Test Bests Fecal Immunochemical Test With Higher Sensitivity for CRC - 10 month(s) ago
Higher sensitivity for CRC and advanced precancerous lesions, but lower specificity for advanced neoplasia, was seen with a next-generation stool DNA test vs a fecal immunochemical test.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Multitargeted DNA Test Bests Fecal Immunochemical Test With Higher Sensitivity for CRC. #oncology #CRC https://t.co/ROPzJlkCyR
-
-
Mashup Score: 1Multitargeted DNA Test Bests Fecal Immunochemical Test With Higher Sensitivity for CRC - 10 month(s) ago
Higher sensitivity for CRC and advanced precancerous lesions, but lower specificity for advanced neoplasia, was seen with a next-generation stool DNA test vs a fecal immunochemical test.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Multitargeted DNA Test Bests Fecal Immunochemical Test With Higher Sensitivity for CRC. #oncology #CRC https://t.co/ROPzJlkCyR
-
FDA Approves Cologuard Plus for Adults at Average Risk for CRC. #oncology #CRC https://t.co/qwbnaCBn4D